Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
NCT07631637
This study is recruiting at 15 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH. In this study, researchers are looking at the effect of ALN-CIDEB on reducing liver fat, liver injury, and liver scarring. The study will compare ALN-CIDEB with placebo to understand how well ALN-CIDEB works to lower the amount of fat in the liver.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Regeneron Pharmaceuticals
- Last updated on ClinicalTrials.gov
- October 26, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 3
- Adobe Clinical Research · Tucson, AZ
- Del Sol Research Management, LLC · Tucson, AZ
- The Institute for Liver Health II LLC dba Arizona Liver Health · Tucson, AZ
California · 2
- California Liver Research Institute · Pasadena, CA
- Inland Empire Clinical Trials · Rialto, CA
Florida · 3
- Universal Axon Clinical Research · Doral, FL
- Genoma Research Group, Inc. · Miami, FL
- Med Research of Florida, LLC · Miami, FL
Louisiana · 2
- Tandem Clinical Research · Marrero, LA
- Tandem Clinical Research · Metairie, LA
Texas · 5
- American Research Corporation · Austin, TX
- Advanced Medical Trials · Georgetown, TX
- Pioneer Research Solutions, Inc. · Houston, TX
- American Research Corporation at The Texas Liver Institute · San Antonio, TX
- Siena Research Network · Sugar Land, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.